Open Access
Subscription or Fee Access
Comparative Study of Vaccine for COVID-19 Available in India
Abstract
The enduring SARS-CoV-2 deadly disease has led to the focused application of resources and scientific knowledge toward the target of developing investigational vaccines to avoid COVID-19. The greatly collaborative global hard work by private industry, governments, and non-governmental organizations has resulted in several SARS-CoV-2 vaccines. In this review, we provide an overview of the description, vaccine characteristic, developers, and action of vaccine, dose & efficacy of vaccines on Covid-19.
Keywords
References
Jon C, Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say, Science (2020),Available online at: https://www.science.org/content/article/russia-s-claim-successful-covid-19-vaccine-doesn-t-pass-smell-test-critics-say
S. V, The Sputnik V Vaccine’s Efficacy is Confirmed at 91.4% based on Data Analysis of the Final Control Point of Clinical Trials, 2020. Available online at: https://sputnikvaccine.com/newsroom/pressreleases/the-sputnik-v-vaccine-s-efficacy-is-confirmed-at-91-4-based-on-data-analysis-of-the-final-control-po/
Balakrishnan V. S. The arrival of Sputnik V, Lancet 2020 Oct;20(10):1128.
Covishield Vaccine Registration, Efficacy rate, Side Effects, Dose Gap. My Personal News for Recruitment and Counselling–MPNRC.Org, 2021 August 11. https://www.mpnrc.org/covishield-vaccine-registration/
Summary of product characteristics. Sputnik V. Gam-COVID-Vac Combined vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus. pp-1-9. Available online at: https://cdsco.gov.in/opencms/resources/UploadCDSCOWeb/2018/Up-loadSmPC/SMPCspu-tinikdr.Reddys.pdf
Jones I, Sputnik V COVID-19 vaccine candidate appears safe and effective; The Lancet 2021 Feb 20;397(10275):642-643.
Raghavan P. Sputnik V now in India: what is the price of Russian vaccine? Indian Express. 2021 May 14. Available online at: https://timesofindia.indiatimes.com/india/sputnik-v-covid-19-vaccine-in-india-all-you-need-to-know/articleshow/83167470.cms
Sputnik Vaccine Registration, Efficacy, Price, Side Effects, Dose Gap. My Personal News for Recruitment and Counselling–MPNRC.Org, 2021 August 11. Available online at: https://www.mpnrc.org/sputnik-vaccine-registration-efficacy-price-side-effects-dose-gap/
Haidar S. More than three million doses of the Russian vaccine will be available by this month. THE HINDU. 2021 May 22. Available online at: https://www.thehindu.com/news/national/coronavirus-more-than-18-million-doses-of-sputnik-v-to-be-made-available-in-india-from-august/article34623321.ece
Covaxin Wikipedia https://en.m.wikipedia.org/wiki/Covaxin
Covaxin-fact-sheet, COVID-19 Vaccine (COVAXIN), Bharat Biotech international Limited. Available online at: https://www.bharatbiotech.com/images/covaxin/covaxin-factsheet.pdf
Parkins K. Covaxin: India’s homegrown COVID-19 vaccine brings hope and controversy. Clinical Trials Arena. 2021 April 27. https://www.clinicaltrialsarena.com/analysis/covaxin-indias-homegrown-covid-19-vaccine-brings-hope-and-controversy/
Corum J. and Zimmer C. How Bharat Biotech’s vaccine works. The New York Times. 2021 May 7. https://www.nytimes.com/interactive/2021/health/bharat-biotech-covid-19-vaccine.html
Bharat biotech covaxin–India’s first Indigenous COVID-19 vaccine. https://www.bharat-biotech.com/covaxin.html
Jeong M. Covaxin COVID-19 vaccine: what to know about side effects. Medical News Today. 2021 June 4. https://www.medicalnewstoday.com/articles/covaxin-covid-19-vaccine-what-to-know-about-side-effects
BS Web Team & Agencies, Covaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results: Covaxin demonstrates significant immunogenicity against the rapidly emerging variants, says Bharat Biotech CMD. Business Standard. 2021 March 3. https://www.business-standard.com/article/current-affairs/covaxin-showed-81-interim-efficacy-bharat-biotech-on-phase-3-results-121030300966_1.html
Sanghi N. Are Bharat Biotech’s Price for Covaxin justified? Science The Wire. 2021 April 27. https://science.thewire.in/health/are-bharat-biotechs-prices-for-covaxin-justified/
BMJ 2021; 373: n997. What do we know about India’s Covaxin vaccine? https://www.bmj.com/content/373/bmj.n997
Ani. Bharat Biotech to ramp up production of Covaxin to 10-12 crore doses by July-end: Dr. NK Arora. The Times of India, 2021 May 31. https://timesofindia.indiatimes.com/india/bharat-biotech-to-ramp-up-production-of-covaxin-to-10-12-crore-doses-by-july-end-dr-nk-arora/articleshow/83114655.cms
Srivatsan K. C. Covishield: A timeline of the COVID-19 vaccine manufactured by Serum Institute of India. Hindustan Times. 2021 January 16. https://www.hindustantimes.com/india-news/covishield-a-timeline-of-the-covid-19-vaccine-manufactured-by-sii-101610818090162.html
Covaxin Vs Covishield Vs Sputnik Vs Pfizer which one should you get? https://www.policybazaar.com/health-insurance/coronavirus-health insurance/articles/compa-rison-covaxin-covishield-sputnikv-pfizer-all-about-covid-19-vaccines-approved-in-india/
Mellet, J., Pepper, M.S. A COVID-19 Vaccine: Big Strides Come with Big Challenges. Vaccines 2021 Jan 11;9(1):39.
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Research & Reviews: A Journal of Immunology